Mast Cells and Its Proteases in COPD

NCT06392334 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2024-04-30

No results posted yet for this study

Summary

Mast cells proteases such as chymase and tryptase will be studied in the tissue of small and large airways in COPD patients

Conditions

  • COPD Exacerbation

Interventions

OTHER

Biopsy

Biopsy of lung tissue

Sponsors & Collaborators

  • Voronezh N.N. Burdenko State Medical Academy

    lead OTHER

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
20 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-01-29
Primary Completion
2025-08-30
Completion
2025-09-30

Countries

  • Russia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06392334 on ClinicalTrials.gov